QIAGEN NV EO -,01 | 42.150 / -1.10% |
Date/Time | 02/25 / 09:48 |
Chg. / Chg.(%) | -0.470 / -1.10% |
Bid | 42.110 / 711 |
Ask | 42.140 / 27 |
Open | 42.630 |
Previous Close | 42.620 |
High | 42.660 |
Low | 42.140 |
Volume [EUR] | 658,772.760 |
Volume [Units] | 15,556 |
Price fixings | 136 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | Xetra |
Type | Stock |
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 42.150 | ![]() |
15,556 |
TradeGate | 42.04 | ![]() |
6,740 |
Cboe Europe .. | 42.14 | ![]() |
6,215 |
Turquoise | 42.18 | ![]() |
2,629 |
Frankfurt | 42.1200 | ![]() |
1,020 |
Stuttgart | 42.130 | ![]() |
950 |
gettex | 42.020 | ![]() |
209 |
London Inter.. | 42.28 | ![]() |
68 |
Cboe Europe .. | 42.18 | ![]() |
63 |
Vienna Globa.. | 42.50 | ![]() |
0 |
München | 42.690 | ![]() |
0 |
Düsseldorf | 42.610 | ![]() |
0 |
Hamburg | 42.500 | ![]() |
0 |
Hannover | 42.720 | ![]() |
0 |
Berlin | 42.600 | ![]() |
0 |
Lang & Schwa.. | 42.110 | ![]() |
|
NYSE | 51.42 | ![]() |
952,578 |
Cboe US | 51.43 | ![]() |
31,786 |
IEX | 51.41 | ![]() |
26,565 |
Cboe Europe .. | 43.15 | 598 | |
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire - OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers
08/11/2020 / 13:30 - GlobeNewswire